Lumida
/MLEC
⌘K
MLEC

MLEC

MLEC
$6.54USD-6.57%-0.46 today

MARKET CAP

4.7M

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $7

52W RANGE

$3
$63

The case for & against

Bull & Bear analysis

Bullish

Mulek Science (NASDAQ: MULEC) specializes in agricultural biotechnology, particularly in molecular farming to produce animal proteins from plant sources, targeting a significant shift towards sustainable food production. Mulek is particularly focused on developing its proprietary PiggySoy platform and the Glasso product, derived from safflower, positioning itself as a disruptive force in the $829 billion agro market by 2025. The company's innovation aims to address challenges like food security and climate change by offering alternatives to traditional animal agriculture.

Bull says

  • USDA approval for PiggySoy eliminates individual permits and fast-tracks market entry
  • FY24 revenues jumped 480% YoY to $5.8M driven by soy protein business consolidation
  • Glasso launch in early 2025 expected to add ~15% to total revenue
  • Secured three-year offtake agreement with leading CPG partner underlining demand
  • Strong book-to-price ratio and positive growth factors signal valuation upside
  • $5.4M cash balance and high quality score indicate financial resilience

Bear says

  • Negative earnings yield and high operational leverage raise liquidity concerns
  • Uncertain customer commitment timing underscores execution risk, per CEO
  • Exposure to Argentina’s inflation and cost volatility could pressure margins
  • Dependence on USDA/FDA approvals may delay product launches and revenue
  • R&D spending rose $9.3M YoY, compressing margins and increasing cash burn
  • High short interest and no dividend yield reduce investor appeal

Earnings Call · Q4 2023 · Mgmt. Guidance

Updated 07-15-2026bullish

Transcript signals

Bull points

  • Mulek's mission is to create unique food ingredients by engineering plants with animal protein genes.
  • it has obtained approvals for specific plants from globally renowned regulatory agencies, including the USDA APHIS and FDA, certifying the safety of crops and initial products.
  • It's crucial to reiterate the incredible opportunity that lies ahead for Moolet, which is equivalent to nearly a trillion dollars in total addressable market.

Bear points

  • During the fiscal year 2023, we faced one of the most severe droughts in our country's history, which led to a decrease in soybean availability resulting in higher prices that are likely to persist until the next harvest expected around May-June 2024.
Read full transcript analysis ›